Results
2266
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2266 companies
GE HealthCare Technologies
Market Cap: US$34.4b
Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
GEHC
US$73.66
7D
3.6%
1Y
-13.6%
Agilent Technologies
Market Cap: US$34.2b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A
US$118.87
7D
4.3%
1Y
-15.0%
Humana
Market Cap: US$33.9b
Provides medical and specialty insurance products in the United States.
HUM
US$281.34
7D
9.8%
1Y
-21.2%
BeOne Medicines
Market Cap: US$33.8b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$309.69
7D
3.8%
1Y
62.2%
IQVIA Holdings
Market Cap: US$32.3b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$189.40
7D
5.8%
1Y
-21.4%
DexCom
Market Cap: US$31.4b
A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
DXCM
US$79.96
7D
4.7%
1Y
10.5%
Mettler-Toledo International
Market Cap: US$27.3b
Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
MTD
US$1,313.64
7D
6.2%
1Y
-8.4%
BioNTech
Market Cap: US$27.1b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$112.70
7D
1.2%
1Y
29.2%
Insmed
Market Cap: US$26.0b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$127.75
7D
16.9%
1Y
72.3%
STERIS
Market Cap: US$24.3b
Provides infection prevention products and services worldwide.
STE
US$246.14
7D
4.2%
1Y
6.9%
Labcorp Holdings
Market Cap: US$22.6b
Provides laboratory services.
LH
US$271.25
7D
4.3%
1Y
20.8%
Insulet
Market Cap: US$21.7b
Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
PODD
US$315.78
7D
4.0%
1Y
61.9%
Natera
Market Cap: US$21.6b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$158.44
7D
12.3%
1Y
29.6%
Sigma Healthcare
Market Cap: AU$33.0b
Operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally.
SIG
AU$2.86
7D
0%
1Y
n/a
Pro Medicus
Market Cap: AU$33.0b
A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.
PME
AU$315.69
7D
-1.3%
1Y
111.8%
Royalty Pharma
Market Cap: US$21.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$36.50
7D
-1.4%
1Y
33.2%
Zimmer Biomet Holdings
Market Cap: US$20.4b
Operates as a medical technology company worldwide.
ZBH
US$102.12
7D
3.7%
1Y
-7.1%
Quest Diagnostics
Market Cap: US$20.0b
Provides diagnostic testing and services in the United States and internationally.
DGX
US$178.44
7D
2.4%
1Y
19.2%
Summit Therapeutics
Market Cap: US$20.0b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$26.45
7D
-5.8%
1Y
122.8%
Biogen
Market Cap: US$19.8b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$134.94
7D
5.6%
1Y
-33.1%
Teva Pharmaceutical Industries
Market Cap: US$19.7b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$17.54
7D
7.7%
1Y
-4.3%
West Pharmaceutical Services
Market Cap: US$17.7b
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
WST
US$246.20
7D
2.4%
1Y
-15.9%
Waters
Market Cap: US$17.7b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$293.52
7D
5.6%
1Y
-13.8%
Incyte
Market Cap: US$16.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$86.16
7D
10.2%
1Y
39.7%
Smith & Nephew
Market Cap: UK£11.8b
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
SN.
UK£13.53
7D
0.6%
1Y
15.6%
Illumina
Market Cap: US$15.5b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$100.09
7D
4.8%
1Y
-22.3%
Hologic
Market Cap: US$15.3b
Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide.
HOLX
US$68.06
7D
0.2%
1Y
-15.5%
Tenet Healthcare
Market Cap: US$15.2b
Operates as a diversified healthcare services company in the United States.
THC
US$172.36
7D
5.5%
1Y
11.1%
Cooper Companies
Market Cap: US$14.8b
Develops, manufactures, and markets contact lens wearers.
COO
US$73.44
7D
6.1%
1Y
-20.2%
United Therapeutics
Market Cap: US$14.0b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$312.06
7D
4.2%
1Y
-3.4%
ICON
Market Cap: US$13.7b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$175.36
7D
11.1%
1Y
-45.5%
Centene
Market Cap: US$13.3b
Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.
CNC
US$26.93
7D
6.6%
1Y
-65.7%
Medpace Holdings
Market Cap: US$13.1b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$458.66
7D
7.0%
1Y
19.3%
Cochlear
Market Cap: AU$20.0b
Provides implantable hearing solutions for children and adults worldwide.
COH
AU$305.99
7D
-2.5%
1Y
-2.2%
Neurocrine Biosciences
Market Cap: US$13.1b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$131.31
7D
4.5%
1Y
-11.1%
Fisher & Paykel Healthcare
Market Cap: NZ$21.8b
Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.
FPH
NZ$37.25
7D
0.7%
1Y
12.5%